about
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombin...
Read More
1.40
0.06
(4.48%)
38,076
XNAS Volume
XNAS 26 Jun, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Bone Biologics Corp is on 03 Jul 2026 for the purpose of Bone Biologics Corp Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Bone Biologics Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..